Abstract:We visualized DNA topoisomerases in A431 cells and isolated chromosomes by isoenzyme-selective immunofluorescence microscopy. In interphase, topoisomerase I mainly had a homogeneous nuclear distribution. 10-15% of the cells exhibited granular patterns, 30% showed bright intranucleolar patches. Topoisomerase II isoenzymes showed spotted (alpha) or reticular (beta) nuclear patterns throughout interphase. In contrast to topoisomerase IIalpha, topoisomerase IIbeta was completely excluded from nucleoli. In mitosis, topoisomerase IIbeta diffused completely into the cytosol, whereas topoisomerases I and IIalpha remained chromosome bound. Chromosomal staining of topoisomerase I was homogeneous, whereas topoisomerase IIalpha accumulated in the long axes of the chromosome arms and in the centriols. Topoisomerase antigens were 2-3-fold higher in mitosis than in interphase, but specific activities of topoisomerase I and II were reduced 5- and 2.4-fold, respectively. These changes were associated with mitotic enzyme hyperphosphorylation. In interphase, topoisomerases could be completely linked to DNA by etoposide or camptothecin, whereas in mitosis, 50% of topoisomerase IIalpha escaped poisoning. Refractoriness to etoposide could be assigned to the salt-stable scaffold fraction of topoisomerase IIalpha, which increased from <2% in G1 phase to 48% in mitosis. Topoisomerases I and IIbeta remained completely extractable throughout the cell cycle. In summary, expression of topoisomerases increases towards mitosis, but specific activities decrease. Topoisomerase IIbeta is released from the heterochromatin, whereas topoisomerase I and IIalpha remain chromosome bound. Scaffold-associated topoisomerase IIalpha appears not to be involved in catalytic DNA turnover, though it may play a role in the replicational cycle of centriols, where it accumulates during M phase.

Physiological regulation of eukaryotic topoisomerase II

Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme

Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.

Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain

Modeling allosteric mechanisms of eukaryotic type II topoisomerases

Cell Cycle Phase-specific Phosphorylation of Human Topoisomerase IIα

Phosphorylation of Serine 1106 in the Catalytic Domain of Topoisomerase IIα Regulates Enzymatic Activity and Drug Sensitivity

Temporospatial control of topoisomerases by essential cellular processes

Human Topoisomerase II Alpha is Phosphorylated in a Cell-Cycle Phase-Dependent Manner by a Proline-Directed Kinase.

Bioinformatic Analysis of Topoisomerase IIα Reveals Interdomain Interdependencies and Critical C-Terminal Domain Residues

Regulation of the Human Topoisomerase IIα Gene Promoter in Confluence-arrested Cells

Casein Kinase II Stabilizes the Activity of Human Topoisomerase IIα in a Phosphorylation-independent Manner

Human topoisomerases and their roles in genome stability and organization

P53 Regulates the Minimal Promoter of the Human Topoisomerase IIalpha Gene.

Inhibition of topoisomerase 2 catalytic activity impacts the integrity of heterochromatin and repetitive DNA and leads to interlinks between clustered repeats

Topoisomerase II Regulates the Maintenance of DNA Methylation

Type II topoisomerases shape multi-scale 3D chromatin folding in regions of positive supercoils

Roles of eukaryotic topoisomerases in transcription, replication and genomic stability

Human Topoisomerase IIα Promotes Chromatin Condensation Via a Phase Transition

Cloning and characterization of the 5'-flanking region of the human topoisomerase II alpha gene.